Though CCL19 and CXCL10 levels differentiated patients with active SLE (with SLEDAI ≥6) from inactive SLE (with SLEDAI ≤2), similar comparison results did not occur between patients with intermediate (with SLEDAI between > 2 and <6) and low lupus activity. The gene discussed is CCL19; the disease is systemic lupus erythematosus.